Kelley Becker
Women's Health · Delaware, OHNPI 1720431224
Payments from drug & device makers
Across 68 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$297
- Mayne Pharma Commercial LLC$188
- Sumitomo Pharma America, Inc.$135
- Exeltis, USA Inc.$104
- Organon$72
- Pfizer$55
- plus $342 from 13 others
What the payments were for
- Food & beverage$1,194100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $297 |
| Mayne Pharma Commercial LLC | 10 | $188 |
| Sumitomo Pharma America, Inc. | 7 | $135 |
| Exeltis, USA Inc. | 7 | $104 |
| Organon | 6 | $72 |
| Pfizer | 3 | $55 |
| Agile Therapeutics, Inc. | 3 | $52 |
| Hologic Sales And Service, LLC | 3 | $50 |
| Coopersurgical, Inc. | 2 | $47 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Aspira Women's Health Inc | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| BD | 1 | $21 |
| Myovant Sciences Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Scynexis, Inc. | 1 | $16 |
| Biogen | 1 | $13 |
| Lupin Inc. | 1 | $13 |
How this compares
$1,194 in reported general payments places this provider in the 80th percentile of 333 women's health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 22 | $1,572 |
| Clobetasol Propionate | 13 | $324 |
| Raloxifene Hcl | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Other women's health in Delaware
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
- Cindy FarinaCleveland$10K
- Kathryn Lowry-CollinsLebanon$9K
- Angalesia RuckerCleveland$9K
- Vivian RuszkiewiczColumbus$6K
- Lauren ZugaWarren$6K
- Lisa LeeseOregon$5K
- Carrie BottiggiMayfield Heights$5K
- Tammy LawsonZanesville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.